Vera Popović

Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas

Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions

Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in <i>POLR3A</i>, <i>POLR3B</i>, and <i>POLR1C</i>

Sensitivity and specificity of the macimorelin test for diagnosis of AGHD

New causes of hypophysitis

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Macimorelin as a Diagnostic Test for Adult GH Deficiency

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome